Acino sales and marketing update

Acino launched a generic version of Exelon Patch rivastigmine from Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland) in the U.S. Exelon Patch, an acetylcholinesterase (AChE) inhibitor, is approv...